Experience with adriamycin, bleomycin, vincristine (ABV) palliative chemotherapy in advanced AIDS-related Kaposi's sarcoma

Journal of Chemotherapy

Volumn 8, Issue 5, 1996, Pages 403-406

  Paparizos, V A ^a   Kyriakis, K P ^b,c   Mileounis, K A ^a   Pfandl Polydorou, D ^a   Stavrianeas, N G ^a   Vareltzidis, A G ^a   Stratigos, J D ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Western Attica General Hospital   (Greece)

^c NONE   (Greece)

Author keywords

Adriamycin; AIDS; Bleomycin; Kaposi's sarcoma; Karnofsky score; Survival; Vincristine

Indexed keywords

BLEOMYCIN; DOXORUBICIN; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLITIS; DIARRHEA; GASTRITIS; HUMAN; KAPOSI SARCOMA; LEUKOPENIA; MALE; NEUROPATHY; RESPIRATORY TRACT INFECTION; STOMATITIS; SURVIVAL; THROMBOCYTOPENIA;

EID: 0029901767     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1996.8.5.403     Document Type: Article

References (11)

1. Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immunodeficiency syndrome: a protocol for uniform evaluation, response and staging criteria. J Clin Oncol 1989; 7: 1201-7.
2. Gill PS, Rarick MV, Espina B, et al. Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Cancer 1990; 65: 1074-78.
3. Cadranel JL, Kammoun S, Chevret S, et al. Results of chemotherapy in 30 AIDS patients with symptomatic pulmonary Kaposi's sarcoma. Thorax 199-1; 49: 958-60.
4. Safai B, Schwarz JJ. Kaposi's sarcoma and the acquired immunodeficiency syndrome. In: De Vita VT, Hellman S and Rosenberg SA (eds): AIDS etiology, diagnosis, treatment and prevention, third edition, JB Lippincott Co, Philadelphia USA, 1992; 12: 209-23.
5. Vamvakas E, Kaplan US. Early transfusion and length of survival in acquired immune deficiency syndrome experience with a population receiving medical care at a public hospital. Transfusion 1993; 33: 111-8.
6. Sloand E, Kumar P, Klein HG, Merritt S, Sacher R. Transfusion of blood components to persons infected with human immunodeficiency virus type 1: relationship to opportunistic infection. Transfusion 1994; 34: 48-53.
7. Williams WJ, Beutler E, Erslev AJ, Lichtman MA, eds: Hematology, 4th Edition, Me Graw-Hill International Edition, 1991.
8. Zoumpourlis V, Kerr DJ, Spandidos DA. Doxorubicin stimulates transcription from the human immunodeficiency virus long terminal repeat sequences. Cancer Lett 1991; 56(2): 181-5.
9. Drabick JJ, Williams WJ, Tang DB, et al. CD4 lymphocyte decline and survival in human immunodeficiency virus infection. AIDS Res 1992; 8(12): 2039-47.
10. Osoba D. Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 1994; 12: 608-16.
11. Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988; 259: 1185-9.